Literature DB >> 11029407

Beta(2)-adrenergic and several other G protein-coupled receptors in human atrial membranes activate both G(s) and G(i).

J D Kilts1, M A Gerhardt, M D Richardson, G Sreeram, G B Mackensen, H P Grocott, W D White, R D Davis, M F Newman, J G Reves, D A Schwinn, M M Kwatra.   

Abstract

Cardiac G protein-coupled receptors that couple to Galpha(s) and stimulate cAMP formation (eg, beta-adrenergic, histamine, serotonin, and glucagon receptors) play a key role in cardiac inotropy. Recent studies in rodent cardiac myocytes and transfected cells have revealed that one of these receptors, the beta(2)-adrenergic receptor (AR), also couples to the inhibitory G protein Galpha(i) (activation of which inhibits cAMP formation). If beta(2)ARs could be shown to couple to Galpha(i) in the human heart, it would have important ramifications, because levels of Galpha(i) increase with age and in failing human heart. Therefore, we investigated whether beta(2)ARs in the human heart activate Galpha(i). By photoaffinity labeling human atrial membranes with [(32)P]azidoanilido-GTP, followed by immunoprecipitation with antibodies specific for Galpha(i), we found that Galpha(i) is activated by stimulation of beta(2)ARs but not of beta(1)ARs. In addition, we found that other Galpha(s)-coupled receptors also couple to Galpha(i), including histamine, serotonin, and glucagon. When coupling of these receptors to Galpha(i) is disrupted by pertussis toxin, their ability to stimulate adenylyl cyclase is enhanced. These data provide the first evidence that beta(2)AR and many other Galpha(s)-coupled receptors in human atrium also couple to Galpha(i) and that abolishing the coupling of these receptors to Galpha(i) increases the receptor-mediated adenylyl cyclase activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11029407     DOI: 10.1161/01.res.87.8.705

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  33 in total

1.  The ups and downs of Gs- to Gi-protein switching.

Authors:  Stephen J Hill; Jillian G Baker
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

2.  Cardiac implications for the use of beta2-adrenoceptor agonists for the management of muscle wasting.

Authors:  Peter Molenaar; Lu Chen; William A Parsonage
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

3.  Systemic administration of beta2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses.

Authors:  James G Ryall; Martin N Sillence; Gordon S Lynch
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

4.  G protein-coupled receptors in cardiac biology: old and new receptors.

Authors:  Simon R Foster; Eugeni Roura; Peter Molenaar; Walter G Thomas
Journal:  Biophys Rev       Date:  2015-01-13

5.  Regulation of cardiac alternans by β-adrenergic signaling pathways.

Authors:  Stela M Florea; Lothar A Blatter
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-08-17       Impact factor: 4.733

6.  Lifetime of muscarinic receptor-G-protein complexes determines coupling efficiency and G-protein subtype selectivity.

Authors:  Olga S Ilyaskina; Horst Lemoine; Moritz Bünemann
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-23       Impact factor: 11.205

7.  Peptidergic signaling from clock neurons regulates reproductive dormancy in Drosophila melanogaster.

Authors:  Dóra Nagy; Paola Cusumano; Gabriele Andreatta; Ane Martin Anduaga; Christiane Hermann-Luibl; Nils Reinhard; João Gesto; Christian Wegener; Gabriella Mazzotta; Ezio Rosato; Charalambos P Kyriacou; Charlotte Helfrich-Förster; Rodolfo Costa
Journal:  PLoS Genet       Date:  2019-06-13       Impact factor: 5.917

Review 8.  Genetically changed mice with chronic deficiency or overexpression of the beta-adrenoceptors--what can we learn for the therapy of heart failure?

Authors:  Samuel Lee; Robert H G Schwinger; Klara Brixius
Journal:  Pflugers Arch       Date:  2007-09-14       Impact factor: 3.657

9.  PDE3, but not PDE4, reduces β₁ - and β₂-adrenoceptor-mediated inotropic and lusitropic effects in failing ventricle from metoprolol-treated patients.

Authors:  Peter Molenaar; Torsten Christ; Rizwan I Hussain; Andreas Engel; Emanuel Berk; Katherine T Gillette; Lu Chen; Alejandro Galindo-Tovar; Kurt A Krobert; Ursula Ravens; Finn Olav Levy; Alberto J Kaumann
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

10.  Laminin enhances beta(2)-adrenergic receptor stimulation of L-type Ca(2+) current via cytosolic phospholipase A(2) signalling in cat atrial myocytes.

Authors:  M R Pabbidi; X Ji; A M Samarel; S L Lipsius
Journal:  J Physiol       Date:  2009-08-24       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.